[Ocrelizumab-associated severe neutropenia: an underestimated complication of treatment of multiple sclerosis with anti-CD20 antibodies?]

MeSH terms

• Antibodies, Monoclonal, Humanized / adverse effects
• Humans
• Immunologic Factors / adverse effects
• Multiple Sclerosis* / drug therapy
• Multiple Sclerosis, Relapsing-Remitting* / drug therapy
• Neutropenia* / chemically induced
• Neutropenia* / diagnosis